我如何治疗1型等离子素缺乏症
Amy D Shapiro1, Charles Nakar2
1Indiana Hemophilia & Thrombosis Center, Inc, Indianapolis, Indiana, United States.
Blood
|March 16, 2025
概括
1型血素缺乏症 (PLGD) 是一种极为罕见的疾病,导致粘膜病变. 静脉注射等离子素缩剂是FDA唯一批准的治疗方法,有助于病变的解决和改善患者的治疗结果.
科学领域:
- 遗传学和血液学
- 罕见疾病 罕见疾病
- 生物化学 生物化学
背景情况:
- 1型等离子原缺乏症 (PLGD) 是一种极为罕见的遗传疾病,由PLG病原变异引起,导致等离子原水平降低.
- PLGD表现为富含纤维素的粘膜伪膜,可能损害器官功能,降低生活质量,并构成危及生命的风险.
研究的目的:
- 展示1型等离子素缺乏症的诊断和治疗策略的临床图片.
- 强调及时诊断和对PLGD患者的一致管理的重要性.
主要方法:
- 对PLGD的临床病例和诊断方法的审查.
- 讨论治疗策略,包括静脉注射等离子素缩物 (IV PLG).
- 突出基因测试和多学科护理中心的作用.
主要成果:
- 由于PLGD的罕见性和模仿其他疾病的各种初始症状,延迟诊断是常见的.
- 静脉注射人体血衍生的Glu-plasminogen (IV PLG缩物) 是FDA批准的第一个也是唯一的病变回归治疗方法.
- 根据疾病的严重程度,个性化治疗计划,包括预防,至关重要.
结论:
- 即使在无症状个体中,迅速识别和管理PLGD至关重要.
- 多学科的护理,通常在专门的中心,如血友病治疗中心,对于最佳的患者的结果至关重要.
- IV PLG缩剂为管理PLGD表现提供了一种特定且有效的治疗选择.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
586
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
586
01:16Clot Retraction and Fibrinolysis
3.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.1K
01:22Formation of the Platelet Plug
3.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.5K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
141
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
141
01:05Introduction to Hemostasis
4.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
4.7K
01:24Disorders of Hemostasis
674
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
674